Exploring Patient Engagement Patterns and Participation Trends in Mantle Cell Lymphoma Clinical Trials
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 500
- 试验地点
- 1
- 主要终点
- Number of patients who decide to enroll in a mantle cell lymphoma clinical study
研究概览
简要总结
Clinical studies with a distinct emphasis on mantle cell lymphoma play a pivotal role in evaluating the safety and effectiveness of novel treatments for this disease. These trials are instrumental in ascertaining whether new medications surpass conventional therapies, providing substantial evidence to endorse their broad utilization.
This particular study stands out as it centers on the firsthand experiences of individuals battling mantle cell lymphoma who are actively engaged in a clinical trial featuring medicinal interventions. The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this patient group.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Confirmed diagnosis of mantle cell lymphoma
- •No serious medical or psychiatric illness likely to interfere with participation in this clinical study.
- •Ability to understand and the willingness to sign a written informed consent document.
排除标准
- •Concurrent participation in another therapeutic clinical trial.
- •Subject has an uncontrolled infection
- •Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
结局指标
主要结局
Number of patients who decide to enroll in a mantle cell lymphoma clinical study
时间窗: 3 months
Rate of patients who remain in a mantle cell lymphoma clinical study to trial completion
时间窗: 12 months
次要结局
未报告次要终点